menu
    • menu

    Company profile for Pyxis Oncology

    NEW Drugs in Dev: 7
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Pyxis Oncology has assembled a differentiated portfolio of potent biologics, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to further improve the outcome for patients with cancer. Charting a course to therapeutics for difficult-to-treat cancer. Pyxis is advancing a diverse portfolio of immunotherapies that target broad immune regulatory mechanisms as well as novel im...
    Pyxis Oncology has assembled a differentiated portfolio of potent biologics, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to further improve the outcome for patients with cancer. Charting a course to therapeutics for difficult-to-treat cancer. Pyxis is advancing a diverse portfolio of immunotherapies that target broad immune regulatory mechanisms as well as novel immune checkpoints with the potential to transform the cancer treatment landscape.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Pyxis OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    35 Cambridgepark Drive Cambridge
    Telephone
    Telephone
    02140 (617) 221-9059
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://pyxisoncology.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pyxis Oncology To Participate In Upcoming Investor Conferences
    Pyxis Oncology To Participate In Upcoming Investor Conferences

    13 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/13/3293881/0/en/pyxis-oncology-to-participate-in-upcoming-investor-conferences.html

    GLOBENEWSWIRE
    13 May 2026
    Share Share
    Pyxis Oncology Appoints Nelson Azoulay As Chief Business Officer
    Pyxis Oncology Appoints Nelson Azoulay As Chief Business Officer

    07 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/07/3290537/0/en/pyxis-oncology-appoints-nelson-azoulay-as-chief-business-officer.html

    GLOBENEWSWIRE
    07 May 2026
    Share Share
    Pyxis Shows Anti-Tumor Combo Data in HNSCC at AACR 2026
    Pyxis Shows Anti-Tumor Combo Data in HNSCC at AACR 2026

    19 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7187989

    FIRSTWORD PHARMA
    19 Apr 2026
    Share Share
    Pyxis Oncology Updates Business & Releases 2025 Financial Results
    Pyxis Oncology Updates Business & Releases 2025 Financial Results

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260234/0/en/Pyxis-Oncology-Provides-Business-Update-and-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share
    Pyxis Oncology Names Interim CEO For Strategic Program Continuity
    Pyxis Oncology Names Interim CEO For Strategic Program Continuity

    03 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/03/3230875/0/en/Pyxis-Oncology-Announces-Interim-CEO-Appointment-and-Leadership-Transition-to-Support-Strategic-Focus-and-Program-Continuity.html

    GLOBENEWSWIRE
    03 Feb 2026
    Share Share
    Pyxis Oncology Reports Positive Ph 1 Results For MICVO In Cancer
    Pyxis Oncology Reports Positive Ph 1 Results For MICVO In Cancer

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3207556/0/en/Pyxis-Oncology-Announces-Positive-Preliminary-Phase-1-Data-for-Micvotabart-Pelidotin-MICVO-in-Recurrent-Metastatic-Head-and-Neck-Squamous-Cell-Carcinoma.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search